Us Bancorp »

Biomarin Pharma Inc convertible/ shares owned by Us Bancorp

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Us Bancorp

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 73k 0.99
2023-09-30 $71k 73k 0.97
2023-06-30 $72k 73k 0.98
2023-03-31 $75k 73k 1.03
2022-12-31 $78k 73k 1.06
2022-09-30 $72k 73k 0.99
2022-06-30 $72k 73k 0.99

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Rus Mid Cap Etf (IWR)
Eli Lilly & Co. (LLY)
Ishares Core Msci Emkt (IEMG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Us Bancorp

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/